|
Profile:
Associate Professor Anthony Harris is Deputy Director of the Centre for Health Economics with responsibility for teaching. The Monash University health economics research degree program, double degree in economics and biomedical science, industry cadetship and scholarship programs, and the off campus flexible learning courses represent the most comprehensive set of programs in health economics anywhere in the world.
Anthony has held teaching and research positions at the University of Aberdeen, University of Western Australia and Murdoch University and has over 50 refereed articles and book chapters, with 30 in health economics, and the rest in other quantitative areas of economics.
He has been closely involved in the application of health economics to health technology assessment and in collaboration with the Monash Institute of Health Services Research currently runs a multidisciplinary health technology research team at Monash University . He has been closely involved in health services decision making as member of the Economics Sub-committee of the PBAC, and member of government review committees in the areas of diagnostic radiology and radiation oncology.
Other research interests include the econometric modeling of health care systems on which CHE was awarded a 5 year national program grant in 2005.
Current national competitive grants
• Efficacy of physiotherapy after hydrodilatation for the stiff painful shoulder: a randomised placebo-controlled trial, with R Buchbinder, S Green, A Forbes and K Bennell
• The IDEAL trial – initiating dialysis early and late, with D Harris, C Pollock, J Craig and A Rodgers
• Using evidence to set priorities in health, with S Hill
• Efficacy of physiotherapy for rotator cuff: a randomised control trial, with K Bennell, S Green and R Buchbinder
• Modeling the economics of the Australian health care system with J Richardson, P Dixon, A Harding
Recent publications include:
Gospodarevskaya E, Goergen S, Harris A , et al. Economic evaluation of a clinical protocol for diagnosing emergency patients with suspected pulmonary embolism. Cost Effectiveness and Resource Allocation 2006, 4:12.
Harris A, Gospodarevskaya E. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 2005; 23(1):77-91.
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Dempster J, Fraenkel MB, Harris A, et al. The initiating dialysis early and late (IDEAL) study: study rationale and design. Peritoneal Dialysis International 2004; 24(2):176-181.
Harris A, Bulfone L. Evaluation for reimbursement of medical therapy in Australia, in T Jost (ed) Technology Assessment for Coverage Policy: a Multi-National Study. 2004, Open University Press.
Harris A. The cost effectiveness of prenatal ultrasound screening for Trisomy 21. International Journal of Technology Assessments in Health Care 2004; 20(4):464-468.
Vu T, Harris A, Gospodarevskaya E. Creutzfeld-Jakob disease: a review of current knowledge. Victorian Infectious Diseases Bulletin 2004; 7(1):2-5.
Vu T, Harris A. Gospodarevskaya E. Improved infection control in the prevention of variant Creutzfeldt-Jakob disease in Australia: costs and benefits. Australia and New Zealand Journal of Public Health 2004; 28(6):57-64.
|
